Setofilm approved in Europe

BioAlliance Pharma S.A. (Euronext:BIO) said Setofilm ondansetron was approved in 16 European countries, including France, Germany and the U.K. The dissolving oral film strip formulation of the serotonin (5-HT3) receptor antagonist is indicated to treat and prevent chemotherapy- and radiation-induced nausea and vomiting and post-operative nausea and vomiting (PONV). The application was approved under the EU's decentralized procedure, with Belgium acting as the reference member state. ...